… Myelodysplastic syndromes are clonal … to acute myeloid leukaemia in a third of patients.
15% of cases occur after chemotherapy or radiotherapy for a previous cancer; the syndromes …

… dominant familial MDS/AL predisposition syndromes detailed … the severe TBD variant
Hoyeraal–Hreidarsson syndrome when … Although no cases of an autosomal dominant familial …

… of acute leukemias (AL) and myelodysplastic syndromes (MDS) was one of the first areas
where monoclonal antibodies were applied (1-3). Ini-tially, indirect imrnunofluorescence …

… discriminant of leukaemic risk it does not emphasize that patients with … myelodysplastic
syndromes, was performed to define the natural history of these disorders and their leukaemic risk…

… or acute myelogenous leukemia (AML). Risk-adapted … Myelodysplastic syndrome (MDS) is
a clonal disorder … by frequent development of acute myelogenous leukemia (AML). Peripheral …

… patients with higher-risk myelodysplastic syndromes (MDS) and acute myeloid leukaemia
(AML), … This article reviews the clinical efficacy and tolerability of azacitidine in the treatment of …

… that the distinction from acute leukaemia was sometimes … MDS, the disease underwent
transformation to a more acute phase often indistinguishable from overt acute myeloid leukaemia. …

… (CHIP) to secondary acute myeloid leukaemia (sAML), MDS is distinguished by the … acute
leukaemia. More than 50 recurrently mutated genes are involved in the pathogenesis of MDS, …

… progressed to acute leukaemia. In 1973 Saarni and Linman reviewed ‘pre-leukaemic’anaemia
and proposed that these were primarily a marrow disorder distinct from acute leukaemia, …

… Acute leukaemia or advanced myelodysplastic syndrome (MDS ≥ 5% blasts) in Fanconi …
We report 21 FA patients with acute leukaemia or advanced MDS who underwent …